Results 121 to 130 of about 65,642 (180)

Nerve growth factor (NGF) [PDF]

, 1989
Azzi, Angelo, Borasio, Gian Domenico, Drahota, S., Heumann, R., Lindholm, D., Papa, S., Thoenen, Hans   +6 more
core  

Targeting the MAPK Pathway in Brain Tumors: Mechanisms and Therapeutic Opportunities. [PDF]

Cancers (Basel)
Vrachas D, Kosma E, Giannopoulou AI, Margoni A, Gargalionis AN, El-Habr EA, Piperi C, Adamopoulos C.   +7 more
europepmc   +1 more source

Successful treatment with sintilimab plus anlotinib for SMARCA4-deficient non-small cell lung cancer withMET exon 14 skipping: a case report. [PDF]

Nagoya J Med Sci
Zhao H, Zhang C, Chen D, Ye W, Shi Q.
europepmc   +1 more source

Biomarker analysis from a Phase 1/1b study of tusamitamab ravtansine in patients with advanced non-small cell lung cancer. [PDF]

Transl Oncol
Gazzah A, Ternès N, Lee JS, Wang E, Carene D, Wang H, Masson N, Boitier E, Lartigau A, Mace N, Chadjaa M, Dib C, Nunes M, Muzard G, Longuemaux-Valence S, Bauchet AL.   +15 more
europepmc   +1 more source

Comprehensive map of the regulatory network triggered by MET exon 14 skipping reveals important involvement of the RAS-ERK signaling pathway. [PDF]

Cell Death Dis
Truong MJ, Pawlak G, Meneboo JP, Sebda S, Fernandes M, Figeac M, Elati M, Tulasne D.   +7 more
europepmc   +1 more source

Good response with nivolumab and cabozantinib combination therapy in patients with metastatic collecting duct carcinoma with high expression of PD-L1, c-MET, and AXL. [PDF]

CEN Case Rep
Umemoto T, Hasegawa M, Naruse J, Kano T, Nakajima N, Nitta M, Kawamura Y, Kajiwara H, Shoji S.   +8 more
europepmc   +1 more source

Crizotinib in Patients with Tumors with MET Amplification or Exon 14 Deletion: Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocols C1 and C2. [PDF]

Clin Cancer Res
Coleman N, Wei Z, Iafrate AJ, Zwiebel JA, Sharon E, Gray RJ, Wang V, McShane LM, Rubinstein LV, Patton DR, Williams PM, Hamilton SR, Takebe N, Williams T, Croley JJ, Onitilo AA, Tricoli JV, Cheng J, Karlovich C, Conley BA, Arteaga CL, Harris L, O'Dwyer PJ, Hong DS, Chen AP, Flaherty KT.   +25 more
europepmc   +1 more source

Rosa roxburghii Tratt. enhances fracture healing through multitarget regulation of osteogenesis and angiogenesis: Integrated network pharmacology and molecular docking analysis. [PDF]

Medicine (Baltimore)
Wu Z, Luo P, Liu H, Xu J, Ying Q, Zhang J, Xuan Z.   +6 more
europepmc   +1 more source

Protein kinase-related tumors in the pediatric population : Updated review on an emerging group with emphasis on the more rarely involved kinases. [PDF]

Pathologie (Heidelb)
Flucke U, Versleijen-Jonkers YMH, Mentzel T, Mueller AM, Hiemcke-Jiwa LS, Alaggio R.   +5 more
europepmc   +1 more source

Case Report: HGF and NF1 mutations as putative bypass mechanisms of MET inhibitor resistance in hepatocellular carcinoma: a case study. [PDF]

Front Pharmacol
Chen Z, Luo S, Gu Y, Li Q.
europepmc   +1 more source